Effect of enzyme replacement therapy on Fabry cardiomyopathy: evaluation of cardiac function is more useful than structural evaluation

Eur Heart J Cardiovasc Imaging. 2021 Sep 20;22(10):e148. doi: 10.1093/ehjci/jeab078.
No abstract available

MeSH terms

  • Cardiomyopathies* / diagnostic imaging
  • Cardiomyopathies* / drug therapy
  • Enzyme Replacement Therapy
  • Fabry Disease* / diagnostic imaging
  • Fabry Disease* / drug therapy
  • Humans
  • alpha-Galactosidase

Substances

  • alpha-Galactosidase